Dallas TX 8/20/2009 10:26:23 PM
News / Business

ASFX, EDAP, BBDA, IMGW, CWRN, SPDE OTCPicks.com Stocks to Watch for Thursday, August 20th

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover's Digest Newsletter, and Email Stock Watch Alerts.

Our Stocks to Watch tomorrow include American Scientific Resources Inc. (OTC: ASFX), EDAP TMS SA (Nasdaq: EDAP), Bebida Beverages Co. (OTC: BBDA), IMAGE Worldwide Inc. (OTC: IMGW), Cotton & Western Mining Inc. (OTC: CWRN) and Speedus Corp. (Nasdaq: SPDE).

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover's Digest Newsletter, and Email Stock Watch Alerts.

AMERICAN SCIENTIFIC RESOURCES INCORPORATED (OTC: ASFX)

"Up 757.14% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/ASFX.php

American Scientific Resources, Inc. is a holding company for two wholly owned subsidiaries, Kidz-Med, Inc. and Heart Smart System. The Company's objective is to locate and acquire innovative health and safety products that are successfully sold abroad, and to introduce and promote them to the North American market.

ASFX News:


August 19 - American Scientific Resources To Be Exclusive Seller of World's Only FDA Approved Home Needle Destruction Device

Enormous potential to become a world leader in its market

In keeping with its mission to provide unique products that greatly benefit the wellbeing of families, American Scientific Resources (the Company) (OTC: ASFX) announced it has obtained from Safeguard Medical Technologies, LLC exclusive worldwide rights to sell and market home Needle Destruction Devices (NDD) known as the Disintegrator™ and the Disintegrator Plus™.

All current and future sales and contracts worldwide have been granted to the Company.

Currently the only NDD approved for home use by the U.S. Food and Drug Administration, the Disintegrator enables patients who need to give themselves injections to properly and safely dispose of their used needles at home. The Disintegrator utilizes a unique plasma arc to melt the needle at a temperature of over 3000 degrees Fahrenheit (ensuring the elimination of any pathogens), reducing it to a small bb-shaped ball. It uses patented technology that gives it distinct advantages over similar devices.

"We are quite pleased to have acquired exclusivity on such an innovative product as the Disintegrator," stated Dr. Christopher F. Tirotta, CEO of American Scientific Resources, Inc. "Potential worldwide sales look most encouraging."

The Disintegrator has enormous potential to become a world leader in its market. For example, multiple sclerosis, diabetes and HIV Patients may require daily injections; this device will ensure that their syringes do not end up harming anyone from family members to waste haulers.

A congressional bill (S, 1312) is pending which would amend Title XVIII of the Social Security Act to provide for coverage of supplies associated with the injection of insulin, of containment, removal, decontamination, and disposal of home-generated needles, and syringes, through a sharps container, or decontamination/destruction device under part D of the Medicare program.

The Disintegrator is already gaining a warm reception from the market. In March 2009, Safeguard delivered 5000 units to one of the world's largest healthcare enterprises. Since then, that global enterprise has placed an additional order for 2000 Disintegrator units (which American Scientific Resources will fulfill) and a competing healthcare enterprise has expressed interest to procure an even larger supply than the combined orders above.

Additionally, according to Safeguard, the first enterprise has a specialty injection drug that is one of the top selling drugs in their line up. Eventually they would like to have a Disintegrator in every such user's home in the EU within 3 years; that translates to over 200,000 units; there are approximately 2 million specialty injection drug users worldwide. With health care transitioning into the home from the facility, ASFX sees the device as a global leader in Needle Disposal Technology.

The Company plans to introduce the product commercially in the fall of 2009. The private label, proprietary models being marketed to the large healthcare enterprises will be sold for upwards of $120. The Disintegrator is EPA recommended.


EDAP TMS S.A. (NASDAQ: EDAP)

"Up 206.57% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/EDAP.php

EDAP TMS SA develops and markets Ablatherm, the most advanced and clinically proven choice for high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer. HIFU treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects. Ablatherm-HIFU is generally recommended for patients with localized prostate cancer (stages T1-T2) who are not candidates for surgery or who prefer an alternative option, or for patients who failed radiotherapy treatment. Approved in Europe as a treatment for prostate cancer, Ablatherm-HIFU (High Intensity Focused Ultrasound) is currently undergoing evaluation in a multicenter U.S. Phase II/III clinical trial under an Investigational Device Exemption granted by the FDA, the ENLIGHT U.S. clinical study. The Company also is developing this technology for the potential treatment of certain other types of tumors. EDAP TMS SA also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL).


EDAP News:


August 19 - EDAP Receives U.S. FDA 510(k) Approval for Sonolith I-Sys


Novel, Innovative and Robotized Next-Generation Lithotripsy Device to Enter U.S. Market


EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced that the U.S. Food and Drug Administration has granted 510(k) marketing clearance for its newly designed, high-end Sonolith I-Sys device.


Sonolith I-Sys is a novel, robotized device that has been developed by EDAP to provide a highly effective product configuration to address what is one of the largest lithotripsy markets in the world. The integrated lithotripter utilizes EDAP's unique and patented electroconductive technology, an advanced shockwave approach differentiated by its superior ability to successfully disintegrate urinary stones in association with combined x-ray or ultrasound systems.


The Sonolith I-Sys received CE mark approval in July 2007 and was launched in the E.U. in late 2007. The device's superior x-ray and ultrasound imaging systems and user friendly features have contributed to its impressive adoption, positive treatment outcomes and high standards that benefit both patients and hospitals.


Marc Oczachowski, EDAP's Chief Executive Officer, said, "We are very pleased that the U.S. FDA has granted 510(k) approval for Sonolith I-Sys, which marks a clear milestone for EDAP, further validates our technology and supports our objective to expand the Sonolith I-Sys into additional geographic territories. With the U.S. approval, we will be positioned to enter one of the largest global markets for lithotripsy. This is an excellent opportunity for EDAP. We will now actively market Sonolith I-Sys and its patented electroconductive technology. We strongly believe that this is the most advanced and robotized lithotripsy system and that it will play a role in the high end market in the U.S. as it was designed to respond to the specificities of this established market."


BEBIDA BEVERAGE COMPANY (OTC: BBDA)

"Up 75.00% on Wednesday"


Detailed Quote: http://www.otcpicks.com/quotes/BBDA.php


The company, formerly known as Fortis Enterprises, was founded in 2000 and is based in Casselberry, Florida. On Sept. 4, 2008, Renovo Holdings announced that the company had changed its name to Bebida Beverage Company and would be locating the base of the company's North American presence in Las Vegas, NV. Bebida Beverage Company hopes to concentrate operations on the bottled water and enhanced beverage markets of North and South America. Bebida's management will focus the company's business efforts within the United States and key target markets within Latin America.


BBDA News:


August 11 - Bebida Beverages Says CHILLAX With a KOMA UNWIND in 2009


Bebida Beverages Company (OTC: BBDA) and its Koma Unwind brand have announced final can design and flavors have been choose and a September full production is now scheduled for Koma Unwind a brand new "Chillaxation Drink Upon the purchase of Bebida Beverages.


CEO Brian Weber had made early on changes to the product portfolio and the direction of the company for the future growth, prosperity and increased shareholder value.


"We got a little ahead of ourselves when we made this change from an energy drink to a relaxation drink early on,” Weber said. “With the economy picking up, designers and flavor houses at capacity, it took a bit longer for us to get the final product where we wanted.”


“We are very happy with the final product and now taking orders from our many distributors looking to add Koma Unwind to their portfolio in the coming months,” Weber added.


Another change aside from design and flavor recently has been the down size from 20 oz bottle to a 12 oz can. “After extensive research it was really a no brainer, as most people unwinding don't care to drink so much liquid before sleep or 'Chillaxing,'” said VP Daisy Ramirez.


Bebida is also excited about continued interest in its products: Potencia Energy Drink, Potencia Blast Energy Shot, Koma Unwind & Piranha Water. The company has been in talks with several national C-Store retailers about co-branding with its NASCAR Camping World Truck Series team and driver. The opportunities for massive media exposure during the NASCAR events along with the marketing rollout make these deals unbelievably viable for retailers. Their investment in Bebida’s team is more about shelf space and purchase orders than hard cash, which during these economic recovery times is more viable.


“It's pretty simple, they purchase our products (which they do anyway) we give them national media exposure and a rallying point with our race team,” said Weber. “We are always looking for retailers that are interested in participating in these type deals.”


Potencia Energy Drink is a 3-year-old all natural fruit energy drink developed for Latino's but loved by everyone! With the initial flavor of Tamarind and the second flavor mandarin due out soon.


Bebida Beverages Co. is the maker and developer of several beverages, including Piranha Water, Guppy Water, Koma Unwind (Chillaxation Beverage) and Koma Shot.


IMAGE WORLDWIDE INCORPORATED (OTC: IMGW)

"Up 100.00% on Wednesday"


Detailed Quote: http://www.otcpicks.com/quotes/IMGW.php


IMAGE Worldwide, Inc. is a full service interactive multimedia marketing, printing, packaging, mailing, advertising, and IT solution agency. IMAGE is vertically integrated with properties including a fashion/entertainment magazine, IT solutions company, promotional and marketing companies, a Packaging company, and a Print and Mailing company. IMAGE utilizes a combination of different forms of media and promotions to help clients showcase and market their IMAGE in print, online, and at events.


IMGW News:


June 17 - IMAGE Worldwide, Inc. Increases First Quarter Revenues in 2009 by Over 135%, Increases Gross Profits by Over 142%


IMAGE Worldwide, Inc. (OTC: IMGW) announce the unaudited results of Operations for the Three Months Ending March 31, 2009 Compared to the Three Months Ended March 31, 2008.


* Revenues for the three months ended March 31, 2009 ("First Quarter 2009") were $1,179,559.97 compared with $501,460 for the three months ended March 31, 2008 ("First Quarter 2008"). That is an increase of 135% or $678,099.97 for the quarter.


* Gross Profits for the three months ended March 31, 2009 ("First Quarter 2009") were $406,780.26 compared with $167,968 for the three months ended March 31, 2008 ("First Quarter 2008"). That is an increase of 142% or $238,812.26 for the quarter.


* Net Income for the three months ended March 31, 2009 ("First Quarter 2009") was $98,563.63 compared with a loss of ($133,257) for the three months ended March 31, 2008 ("First Quarter 2008"). That is an increase of $277,418.16 in Net Profit for the quarter.


COTTON & WESTERN MINING INCORPORATED (OTC: CWRN)

"Up 35.90% on Wednesday"


Detailed Quote: http://www.otcpicks.com/quotes/CWRN.php


Cotton & Western Mining, Inc. was founded in early 2005 as a Nevada Corporation by Robert L. Cotton, with a specific plan and goal in mind; that being, to operate a low cost and high profit junior "Iron Mineral Mining" company. Cotton & Western Mining's mission is to offer reliable, high-quality and cost effective raw materials to the steel manufacturing industry on a global scale.


CWRN News:


August 19 - $32.76 Million Baja Iron Ore Annual Fixed Price Contract Offered


Cotton & Western Mining, Inc. (OTC: CWRN) announced that a major Chinese steel mill has offered a contract for year 2010, 14 shipments of 52,000 dry metric tons each, loading out of the Pacific Ocean Port of Ensenada, Baja California, Mexico, beginning by the end of January 2010. Management will be meeting with the Company's partners in early September to discuss the offer and others that have recently come into the Company. With the recent China Seaborne Trade increase, the Company's website is receiving one to three iron ore inquiries per day. In order to meet a late January shipping date, production at the Baja Pacific Iron Mining Project would need to be in place before the December holidays.


SPEEDUS CORPORATION (NASDAQ: SPDE)

"Up 77.07% on Wednesday"


Detailed Quote: http://www.otcpicks.com/quotes/SPDE.php


Speedus Corp., through its subsidiaries, engages in healthcare, restaurant, and wireless businesses in the United States. The company has co-invested with Siemens Corporate Research, Inc., a subsidiary of Siemens Corporation, in Zargis Medical Corp. to develop advanced diagnostic decision support products and services that automatically analyze acoustical data from a patient to determine physiologically significant features useful in medical diagnosis for primary care physicians, pediatricians, cardiologists, and other healthcare professionals. It owns 90% of F&B Gudtfood, the creator and operator of the original Eurocentric cafe, which operates a store in Manhattan. The company has a portfolio of patents that provide high-speed wireless communication systems. In addition, it offers Local Multipoint Distribution Service (LMDS) license for developing and deploying LMDS technology that is used for various fixed wireless purposes, including wireless local loop telephony, high-speed Internet access, and two-way teleconferencing. The company, formerly known as SPEEDUS.COM, Inc., was founded in 1995 and is based in New York, New York.


SPDE News:


August 19 - John Kallassy Promoted to CFO for Speedus


Speedus Corp. (Nasdaq: SPDE) has promoted John Kallassy to chief financial officer, effective August 12, 2009. Kallassy has served as executive vice president of Speedus since 2001 and will continue serving in the role of chief executive officer of Zargis Medical Corp., a post which he has held for the past 4 years. Zargis is a majority-owned subsidiary of Speedus.


"John has done an outstanding job as Zargis' CEO, where he successfully led the company from its research and development stage to a comprehensive product launch through a global marketing alliance with 3M," stated Shant Hovnanian, Speedus' chairman and CEO. "John's enthusiasm is contagious and he has certainly earned this promotion and expanded role."


Prior to his leadership roles at Zargis and Speedus, John was a founder and the CEO of American Data Consultants (ADC), a firm specializing in information services and market research. John sold ADC to R.L. Polk in 1997 and continued his employment for three years at R.L. Polk as the ADC division president and later as a corporate vice president where he led the product management and analytical consulting groups for the $100 million business unit. John holds a Bachelor of Science degree from the State University of New York which was completed during a year of pharmacology studies at Leeds University in Leeds, England, and earned his MBA from the Johnson School of Management at Cornell University.


OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.


DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.


The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.


Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.


Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stockbroker before investing.


Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward-looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward-looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org/.


Disclosure: OTCPicks.com has been compensated five thousand dollars by a third party for CWRN advertising and promotional services.